On March 15, Qinghai Spring Medicinal Resources Technology Co.Ltd(600381) issued the announcement on abnormal fluctuations in stock trading, which disclosed that the daily closing price of its shares had deviated by 20% in three consecutive trading days on March 11, March 14 and March 15, 2022, belonging to abnormal fluctuations in stock trading.
Recently, affected by multiple factors, the performance of A-Shares has weakened continuously. In Baijiu shares, the Qinghai Spring Medicinal Resources Technology Co.Ltd(600381) performance of listed companies with “Baijiu” liquor selling rights is up to the eye. From January 28, 2022 to March 15th, Qinghai Spring Medicinal Resources Technology Co.Ltd(600381) shares rose 76.30%.
In the announcement, Qinghai Spring Medicinal Resources Technology Co.Ltd(600381) said that in terms of production and operation, through self inspection, the company’s current production and operation activities are normal, the market environment and industrial policies have not been significantly adjusted, the internal production and operation order is normal, and there are no other major matters that should be disclosed but not disclosed except the disclosed information. The company also explained major events, media reports, market rumors, hot spot concepts and other sensitive information about stock prices. In addition, Qinghai Spring Medicinal Resources Technology Co.Ltd(600381) also suggests the secondary market transaction risk, production and operation risk and pledge risk of major shareholders.
Meanwhile, Tibet Rongen Technology Co., Ltd., the controlling shareholder of Qinghai Spring Medicinal Resources Technology Co.Ltd(600381) said in the reply that it did not involve the major matters that Qinghai Spring Medicinal Resources Technology Co.Ltd(600381) should be disclosed but not disclosed.
The river becomes warm in spring, and is understood to be a Qinghai Spring Medicinal Resources Technology Co.Ltd(600381) market leader in the A share market. It should be the capital market “the prophet”, and its subsidiary Baijiu “Sheng Jin Liquor” has been recognized.
In early 2022, Sichuan Yibin listening and flower wine industry launched 58600 yuan a bottle of “listening to flower” boutique Baijiu, which is much concerned by the market. “Listening to flower Baijiu” is controversial because of its high-end positioning and high price. The day before the launch of the “flower wine”, the Qinghai Spring Medicinal Resources Technology Co.Ltd(600381) closed at 8.68 yuan / share, because its subsidiary company had a total distribution rights to hear the flower wine. Its stock price was 11.90 yuan / share as of March 15th, reflecting the capital market’s approval of Qinghai Spring Medicinal Resources Technology Co.Ltd(600381) and its new Baijiu super high end products.
It is understood that the “Baijiu Baijiu” concept was put forward in the market. The introduction of multidisciplinary technology into brewery and the succession of traditional liquor fermentation, the two step fermentation and distillation of alcohol mature wine were carried out to achieve the “gain” of the wine body, and the innovative liquor with an aroma of one inch, three feet thick and a mouth dropping to produce fluid could activate the parasympathetic nerve. Reduce the harm of alcohol to human body and bring health value.
As an industry “innovator” who breaks the rules and leads the new beginning of the market, “listening to peanuts and wine” brightens the eyes of consumers. The market is full of expectations for the new characteristics of “listening to flower wine”.
According to the official website of Tinghua wine, in July 2021, Tinghua wine was invited to become the designated wine of “2021 capital market high quality development forum”; In September 2021, Tinghua wine was invited to be the only designated wine for the “2021 annual meeting of new fortune listed companies”.
Some insiders pointed out that in the past few months since listening to flower wine officially entered and entered the market, consumers, including some practitioners in the capital market, and the trend of Qinghai Spring Medicinal Resources Technology Co.Ltd(600381) share price, to a certain extent, reflects the strong cognition, recognition and acceptance of the product in the capital market, which largely comes from the experience of the product. This shows that the innovation and consumption experience of the wine is successful, and the capital market is full of expectations for the “innovators” in the Baijiu industry.
